Independence Blue Cross has increased local provider options by 47% since 2022, and now offers additional mental health and ...

Results of a survey show that Black/Indigenous/People of Color or Hispanic patients with Crohn's disease or ulcerative ...

When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...

Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

Gold carding eliminates prior authorization for top-performing labs and eases plan workflows while controlling spending and ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

The FDA has approved Lilly’s Ebglyss (lebrikizumab-lbkz) for the treatment of moderate to severe atopic dermatitis in adults ...

Express Scripts alleges in its suit that the FTC followed “prejudice and politics, not evidence or sound economics,” and that ...

The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization ...

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...